MRNA funding rate on Arcus
Over the last 30 days, MRNA funding on Arcus averaged +8.8% APR and stayed positive 99.2% of the time, ranging from -38.8% to +127.3%. Right now it pays shorts pay longs at -22.9% APR, settled every 1h across 13 venues we track. The most reliable delta-neutral pairing for MRNA right now is long TradeXYZ / short Phoenix at +40.7% net APR (low risk, ~0.5d to break even).
MRNA funding history on Arcuslast 30d
- Backtested (30d)
- +5.9%
- Stability
- 76.3%
- Risk
- medium
- Breakeven
- ~0.5d
Ranked by 30-day reliability (backtest × stability × risk) — the spread that holds, not just the widest current rate.
Open this tradeNot ready to trade? Get a Telegram ping when MRNA's delta-neutral funding APR spikes — no sign-up, no wallet needed. The bot confirms your exact watch level.
How MRNA funding compares across venues
Frequently asked
What is the current MRNA funding rate on Arcus?
MRNA on Arcus is funding at -22.89% APR (-0.0026% every 1h), paid shorts pay longs, as of 2026-10-19 21:23 UTC.
How often does Arcus pay funding on MRNA?
Every 1 hour.
How do I earn MRNA funding without price risk?
Open a delta-neutral position: long Arcus and short Phoenix, currently 64.5% net APR (medium risk). The two legs cancel price exposure so you keep the funding spread.